To mark the anniversary a brochure has been produced, which gives background on the programme and two very short films, one on their work goo.gl/9GrGJy, and the other goo.gl/P3QUjO shows how Kenyan researchers have discovered the secret of HAPPYness!
More information on the programme can be found at http://www.kemri-wellcome.org/ and on twitter @KEMRIW
The MultiMalVax CALL is for a suitable European clinical trial site for the conduct of a phase I clinical trial to assess the safety, immunogenicity and ex-vivo efficacy of simian adenovirus (ChAd63) and Modified Vaccinia Ankara (MVA) vectors expressing mosquito stage Plasmodium falciparum antigens. This clinical trial will start in January 2015, enrol 24 volunteers, and should be conducted within 12 months. University of Oxford will act as sponsor of the clinical trial.
Do not wait to register for the workshop organised by the European Vaccine Initiative:
Malaria Vaccine Development in Europe – preparing for the future
20 – 21 November 2014
Louise Centre, Av. Louise 287, Brussels, Belgium
- 1 of 14